These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8797514)

  • 21. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
    Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of borderline ovarian tumors.
    Harlow BL; Weiss NS; Lofton S
    J Natl Cancer Inst; 1987 Jan; 78(1):71-4. PubMed ID: 3025504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland.
    Kumpulainen S; Kuoppala T; Leminen A; Komulainen M; Puistola U; Sankila R; Mäkinen J; Grénman S
    Acta Obstet Gynecol Scand; 2007; 86(5):610-4. PubMed ID: 17464592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.
    Mink PJ; Sherman ME; Devesa SS
    Cancer; 2002 Dec; 95(11):2380-9. PubMed ID: 12436446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases.
    Greggi S; Genuardi M; Benedetti-Panici P; Cento R; Scambia G; Neri G; Mancuso S
    Gynecol Oncol; 1990 Dec; 39(3):300-4. PubMed ID: 2258075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
    Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E
    Acta Oncol; 2016 Nov; 55(11):1281-1284. PubMed ID: 27148621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.
    Rader JS; Neuman RJ; Brady J; Babb S; Temple S; Kost E; Mutch DG; Herzog TJ
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):589-95. PubMed ID: 9764634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991.
    Piver MS; Baker TR; Jishi MF; Sandecki AM; Tsukada Y; Natarajan N; Mettlin CJ; Blake CA
    Cancer; 1993 Jan; 71(2 Suppl):582-8. PubMed ID: 8420680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.
    Kotaniemi-Talonen L; Pukkala E; Aittomäki K; Auranen A
    Acta Obstet Gynecol Scand; 2023 Mar; 102(3):240-245. PubMed ID: 36645194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for progression to invasive carcinoma in patients with borderline ovarian tumors.
    Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2014 Sep; 24(7):1206-14. PubMed ID: 25078337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
    Salazar H; Godwin AK; Daly MB; Laub PB; Hogan WM; Rosenblum N; Boente MP; Lynch HT; Hamilton TC
    J Natl Cancer Inst; 1996 Dec; 88(24):1810-20. PubMed ID: 8961970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood and adolescent ovarian malignant tumors in Israel. A nationwide study.
    Menczer J; Sadetzki S; Murad H; Barda G; Andreev H; Barchana M
    Acta Obstet Gynecol Scand; 1999 Oct; 78(9):813-7. PubMed ID: 10535348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parity, age at first childbirth, and risk of ovarian cancer.
    Adami HO; Hsieh CC; Lambe M; Trichopoulos D; Leon D; Persson I; Ekbom A; Janson PO
    Lancet; 1994 Nov; 344(8932):1250-4. PubMed ID: 7967985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer incidence in the first-degree relatives of ovarian cancer patients].
    Auranen A; Pukkala E; Mäkinen J; Sankila R; Grénman S; Salmi T
    Duodecim; 1997; 113(1):46-50. PubMed ID: 11370054
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ovarian tumors of low malignant potential (borderline ovarian tumors)].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):438-45. PubMed ID: 21870737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segregation analysis of epithelial ovarian cancer in Finland.
    Auranen A; Iselius L
    Br J Cancer; 1998 May; 77(9):1537-41. PubMed ID: 9652774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian cancer incidence and survival in Korea: 1993-2002.
    Chung HH; Hwang SY; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
    Int J Gynecol Cancer; 2007; 17(3):595-600. PubMed ID: 17300678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
    Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
    Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer incidence in the United States, 1992-1999.
    Quirk JT; Natarajan N
    Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.